Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q by Adema, V, Palomo, L, Walter, W, Mallo, M, Hutter, S, La Framboise, T, Arenillas, L, Meggendorfer, M, Radivoyevitch, T, Xicoy, B, Pellagatti, A, Haferlach, C, Boultwood, J, Kern, W, Visconte, V, Sekeres, M, Barnard, J, Haferlach, T, Solé, F, Maciejewski, JP

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS by Malcovati, L, Stevenson, K, Papaemmanuil, E, Neuberg, D, Bejar, R, Boultwood, J, Bowen, DT, Campbell, PJ, Ebert, BL, Fenaux, P, Haferlach, T, Heuser, M, Jansen, JH, Komrokji, RS, Maciejewski, JP, Walter, MJ, Fontenay, M, Garcia-Manero, G, Graubert, TA, Karsan, A, Meggendorfer, M, Pellagatti, A, Sallman, DA, Savona, MR, Sekeres, M, Steensma, DP, Tauro, S, Thol, F, Vyas, P, Van de Loosdrecht, AA, Haase, DT, Tuechler, H, Greenberg, PL, Ogawa, S, Hellstrom-Lindberg, ES, Cazzola, M